Published in Telemedicine Week, October 13th, 2009
"We wished to confirm or refute that K16 and/or its intermediate filament partner, keratin 6 (K6), are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.